As the use of SPRAVATO® (esketamine) grows in the treatment of treatment-resistant depression, many providers are discovering an uncomfortable truth: standard billing companies simply aren’t equipped to handle the complexities of Spravato reimbursement.
At Finnastra, we’ve seen the consequences of generic billing firsthand—and more importantly, we’ve built specialized Spravato Billing Services to solve those challenges.
Most billing vendors treat Spravato like any other medication or behavioral health service. The result?
These issues don’t just affect your bottom line—they affect your patients. When prior authorizations are denied or reimbursement is stalled, access to critical treatment is put at risk.
Billing for SPRAVATO® requires a deep understanding of:
This is not a plug-and-play scenario. You need a team that understands the full scope of Spravato Billing Services, not just behavioral health billing in general.
When evaluating your billing partner, ask:
At Finnastra, we’ve helped clinics reduce denials by over 80%, accelerated claim turnaround times, and built workflows that align with REMS, payer requirements, and real-world clinic needs.
Don’t let generic billing jeopardize your clinic’s revenue—or your patients’ access to life-changing treatment.
As a leading Spravato Billing Company, Finnastra brings specialized knowledge, white-glove support, and proven outcomes to your side. Whether you’re just starting with SPRAVATO® or scaling your program, we’re built to help you succeed.
Let’s Talk:
Reach out to explore how Finnastra’s Spravato Billing Services can protect your revenue, streamline your workflows, and empower your care.